We have demonstrated that NR1D1 is expressed in DMD cells, albeit to a lower extent compared with control human myotubes, suggesting that increasing NR1D1 activity could represent a new therapeutic option in myopathies. The gene discussed is NR1D1; the disease is Duchenne muscular dystrophy.